drugset / Trial / NCT01114971
Labetalol and Esmolol: Vital Signs and Post Operative Pain Management
RandomizedFactorialDouble-blindPrevention
Summary
This study proposes to investigate the effects of labetalol or esmolol on managing the vital signs (like blood pressure and heart rate) during surgery, on pain management, and on the later recovery after surgery. It will also assess the cost-effectiveness of Labetalol and esmolol for outpatient surgery.
Timeline
- Start
- 2009-09-03
- Primary completion
- 2014-07-30
- Completion
- 2018-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esmolol | Other / unclassified | 10 mg/ml | Intravenous |
| Subject | Fentanyl | Other / unclassified | 50 ug/ml | — |
| Subject | Labetalol | Small molecule | 5 mg/ml | — |
Indications
No indication recorded.